Regulatory reading · checked 2026-10-04

The EU AI Act, for people building research tools on AI

The Regulation was amended on 2026-07-27, six days before the date most published commentary still names. This page states what we found in the primary texts, with the article number, the source and the date of every claim — and where our own services sit under it.

Regulation (EU) 2024/1689Base act
Regulation (EU) 2026/1744 (Digital Omnibus on AI)In force 2026-07-27
2026-10-04Sources last checked · 16 days ago
2026-11-03Next review due
16 of 16 Claims whose sources a machine could re-check on 2026-10-04

Every claim's sources were re-checked by machine on the last scan. 16 of 16 claims could be confirmed against their sources. For statutes the machine compares the official list of versions of the text — from the EU Publications Office and from the Swiss federal law database — not the text itself: a match means no new version, corrigendum or amending act has appeared since the text was last read by a person.

What this is. Seven independent research agents read the primary texts on 2026-09-13. Each recorded, for every claim, an article number and a source URL, and a verbatim English quotation wherever the primary text was reachable; each ended with an explicit list of what it could not confirm. Their training data predates the 2026 amendment; the amendment was found in the course of the research, not supplied to them. Where seats disagreed, both readings were kept. A separate seat with no access to the drafting reviewed this page against the dossiers before publication. Re-checked on 2026-10-03 by three agents following the published re-check procedure, each limited to the items that can move; the Commission's Article 50 guidelines were then read against this page on 2026-10-04.

What this is not. This page is a reading of published texts, not legal advice. Where the law is unsettled we say so instead of choosing an answer. No enforcement decision or court judgment interprets any of the undecided points below.

The dataset behind this page is served as JSON, so you can diff one revision against the next. The amendment entered into force six days before the original 2026-08-02 general application date. Commentary written before 2026-07 states dates that are no longer correct. A corrigendum to the amending act was published on 2026-09-29 (CELEX 32026R1744R(01), OJ L 2026/90810); it corrects the German language version only. On 2026-10-03 the consolidated version was still 02024R1689-20260727, and no later act amending Regulation 2024/1689 had been adopted.

When each part starts

The general application date in Article 113 was not amended, so 2026-08-02 held. What the amendment changed, in the same article, was when the high-risk chapter starts.

2024-08-01 done

Regulation (EU) 2024/1689 enters into force.

Art. 113
2025-02-02 applying now

Prohibited practices (Art. 5) and AI literacy (Art. 4) apply.

Art. 4 · Art. 5 · Art. 113
2025-08-02 applying now

General-purpose AI model obligations (Chapter V), governance and penalties apply.

Art. 53-55 · Art. 113
2026-07-27 done

Regulation (EU) 2026/1744 enters into force and moves the high-risk dates.

Reg. 2026/1744
2026-08-02 applying now

General application. Transparency obligations (Art. 50) and GPAI penalties (Art. 101) start. The general application date in Article 113 was not amended, so this date held; the amendment changed the high-risk derogations in the same article.

Art. 50 · Art. 101 · Art. 113
2026-12-02 not yet

Two prohibitions added by the amendment start. Systems on the market before 2026-08-02 must meet Art. 50(2) by this date.

Art. 5(1)(ba) · Art. 5(1)(bb) · Art. 50(2)
2027-12-02 not yet

High-risk obligations for the Annex III route apply. Moved from 2026-08-02 by the amendment, as a fixed calendar date.

Ch. III · Annex III
2028-08-02 not yet

High-risk obligations for the Annex I route (AI embedded in regulated products, including medical devices) apply.

Ch. III · Annex I

16 things worth knowing before you build

Ordered by how often they change a decision, not by article number. Each carries its article, its sources, and whether the point is settled in the text or still open.

TermMeans
providerwhoever develops an AI system, or has it developed, and puts it on the market or into service under their own name — paid or free (Art. 3(3)).
deployerwhoever uses an AI system under their own authority, other than for personal non-professional activity (Art. 3(4)).
Annex I routehigh risk because the AI is a safety component of a product already covered by EU product law — medical devices, machinery, and so on — and that law requires third-party assessment (Art. 6(1)).
Annex III routehigh risk because the intended use is on a list of eight areas — biometrics, critical infrastructure, education, employment, essential services, law enforcement, migration, justice (Art. 6(2)).
notified bodyan independent organisation designated by a Member State to assess conformity before certain products may carry the CE mark.
GPAI modela general-purpose AI model — the large language model itself, as distinct from a system built on top of it (Art. 3(63)).
SME / SMCsmall and medium-sized enterprise, and — a category the amendment added — small mid-cap company. The Regulation borrows the EU's standard size definitions.

Offering it free does not put you outside the Regulation

"Making available on the market" is defined as supply for distribution or use in the course of a commercial activity, "whether in return for payment or free of charge". A free academic service can still be a market act. What the definition turns on is the commercial-activity limb, not the price.

“the supply of an AI system or a general-purpose AI model for distribution or use on the Union market in the course of a commercial activity, whether in return for payment or free of charge”

Being outside the EU does not put you outside it either

The Regulation reaches providers and deployers established in a third country where the output produced by the AI system is used in the Union. For a Swiss, UK or US group with EU users, this is the hook that applies. Note a divergence nobody has resolved: the article says the output "is used" in the Union, while Recital 22 speaks of output "intended to be used" there. The binding text is the article.

“providers and deployers of AI systems that have their place of establishment or who are located in a third country, where the output produced by the AI system is used in the Union”
In the text, one open edge Source re-checked Art. 2(1)(c) · Recital 22 Regulation (EU) 2024/1689, consolidated text ... Article 2 index entry (secondary index, usefu...

Calling someone else's model through an API does not make you a model provider

If you build a service on top of a third-party large language model, you are a provider of an AI system, not a provider of a general-purpose AI model. The model-provider obligations (Art. 53-55: technical documentation, training-data summary, copyright policy) do not attach to you. The Commission's guidelines say the downstream actor integrating the model into a system and placing that system on the Union market may be the provider of the system, and must comply with the requirements for AI systems.

“the downstream actor integrating the model into an AI system and placing the system on the Union market ... may be the provider of the system”
In the text Source re-checked Art. 3(1) · Art. 3(63) · Art. 3(68) Commission guidelines on the scope of the obl... Regulation (EU) 2024/1689, consolidated text ...

Fine-tuning can make you one, though

Retrain the model heavily enough and you become the provider of a new model. The same guidelines propose the line: a downstream actor becomes a model provider when the compute used to modify the model exceeds roughly one third of the compute used to train the original. They also flag a less obvious trap: using an upstream model whose licence terms exclude EU-market use can shift model-provider status downstream. Prompting, retrieval augmentation and system prompts are not addressed in the text; treating them as safe is an inference, not a statement of the guidelines.

Guidance, not the article Source re-checked Art. 3(63) · Art. 51 Commission guidelines on the scope of the obl...

Open-sourcing your system does not exempt you from the transparency rules

The free and open-source exemption is real but narrow: it stops at high-risk systems, at Article 5, and at Article 50. Since Article 50 is the obligation most small AI services actually land on, publishing under a permissive licence buys nothing there. It buys something else worth having — a third party can reproduce your results independently — but not an exemption.

“This Regulation does not apply to AI systems released under free and open-source licences, unless they are placed on the market or put into service as high-risk AI systems or as an AI system that falls under Article 5 or 50.”

The scientific research exemption is narrower than it looks

Article 2(6) excludes systems "specifically developed and put into service for the sole purpose of scientific research and development". It says put into service; it does not say placed on the market. Recital 25 narrows it from three directions, and one of them is decisive for anyone running a tool for other researchers: a system merely used in the conduct of research stays inside the Regulation. The Commission's Article 50 guidelines read Article 2(6) only within Article 50: the exclusion covers the outputs of generative systems used in scientific research, but once a system is put into service, or its outputs are used, for anything other than that sole purpose, the Article 50 duties apply (para. 21). An example the guidelines give right after that paragraph has researchers who "develop and place on the market or put into service" an interactive system for a study and still need not meet the Article 50(1) and (2) duties, which reads more generously than the article's own wording. Neither those guidelines nor any court addresses whether the exclusion covers a tool offered as a service to other researchers.

“any other AI system that may be used for the conduct of any research and development activity should remain subject to the provisions of this Regulation”

Statistics, visualisation and hypothesis testing are not AI systems at all

The Commission's guidelines on the definition of an AI system place several things researchers use daily outside the definition: statistical analysis, data visualisation, hypothesis testing, machine-learning acceleration of physics simulations, and approximations of established optimisation methods such as linear and logistic regression. The question prior to risk tier is whether the definition is met at all. In our own case, one service split this way — its language-model stage inside the definition, its rule-based code scan outside it.

Guidance, not the article Source re-checked Art. 3(1) Commission guidelines on the definition of an...

The high-risk deadlines moved; older commentary gives the wrong date

The amendment moved the Annex III route to 2027-12-02 and the Annex I route to 2028-08-02, as fixed calendar dates. The Commission's earlier proposal to tie the start to standards being ready did not survive. Anything written before 2026-07 gives 2026-08-02 for high-risk, and that is now wrong.

Article 50 is in force now, and it applies regardless of risk tier

Transparency duties sit in their own chapter and do not depend on being high-risk. Two bind providers: telling people they are interacting with an AI system, and marking synthetic content in a machine-readable form. Two bind deployers: disclosing emotion recognition or biometric categorisation, and disclosing deep fakes and AI-generated text published to inform the public on matters of public interest. The information must be given clearly and at the latest at the time of first interaction or exposure. Text counts as published when it is accessible to an indeterminate, fairly large number of unrelated potential readers; a closed private group, private correspondence and organisation-internal documents are not published (Article 50 guidelines, para. 131).

In the text Source re-checked Art. 50(1) · Art. 50(2) · Art. 50(3) · Art. 50(4) · Art. 50(5) Regulation (EU) 2024/1689, consolidated text ... Commission guidelines on transparency obligat... Commission guidelines on the transparency obl...

Two Article 50 carve-outs are worth knowing before you build

The duty to tell a person they are dealing with an AI system does not apply where that is obvious to a reasonably well-informed, observant and circumspect person in the circumstances. The Commission's Article 50 guidelines read this against the EU consumer-law notion of the average consumer, say it is to be interpreted restrictively, and put the burden on the provider to assess and demonstrate it; general awareness that AI systems exist does not make an interaction obvious (paras. 42-45). Their examples include code assistants available only to professional developers and interactive systems used only by properly trained health professionals. The duty to disclose AI-generated text published on matters of public interest does not apply where the text has undergone human review or editorial control and a natural or legal person holds editorial responsibility. The guidelines require review of the substance by people with relevant knowledge, with fact-checking as a minimum; spell-checks, the mere existence of an editorial policy, automated review or cursory approval do not count, and a substantive AI edit after sign-off voids the exception (paras. 133-136). An academic blog under internal peer review, with the research centre holding editorial responsibility, is one of their examples that qualifies (example after para. 138). The guidelines are not binding, and no court has ruled on either carve-out.

“unless this is obvious from the point of view of a natural person who is reasonably well-informed, observant and circumspect, taking into account the circumstances and the context of use”

Annex III has no category for research tools or laboratory analysis

The eight high-risk areas cover biometrics, critical infrastructure, education, employment, access to essential services, law enforcement, migration and border control, and administration of justice. Scientific research, clinical laboratory analysis and genomics appear nowhere. A research platform reaches high risk only by a different route: by being a medical device or IVD requiring notified-body involvement under the Annex I route, or by a specific function landing in one of the sub-points — biometric categorisation, eligibility assessment for public benefits, life and health insurance pricing, or emergency triage.

In the text Source re-checked Art. 6(1) · Art. 6(2) · Annex I · Annex III Regulation (EU) 2024/1689, consolidated text ... MDCG 2025-6 — interplay between the Medical D...

Even when high-risk, most Annex III systems are self-assessed

Article 43(2) states in terms that points 2 to 8 of Annex III follow the internal-control procedure of Annex VI, "which does not provide for the involvement of a notified body". Third-party assessment is required for point 1 (biometrics) in defined circumstances. This is the provision that decides whether a certification body is involved at all. The Commission may change it in future.

“internal control as referred to in Annex VI, which does not provide for the involvement of a notified body”
In the text Source re-checked Art. 43(2) · Annex VI Regulation (EU) 2024/1689, consolidated text ...

You can become the provider of someone else's system without meaning to

Putting your name or trademark on a high-risk system already on the market, making a substantial modification to it (a change not foreseen by the original provider that affects compliance or intended purpose), or changing the intended purpose of a system so that it becomes high-risk — any of these makes you the provider, carrying the provider's full set of duties: documentation, quality management, registration, conformity assessment. For the name-and-trademark case, a contractual allocation between the parties does not undo it.

In the text Source re-checked Art. 25(1) · Art. 16 · Art. 3(23) Regulation (EU) 2024/1689, consolidated text ...

The start dates are fixed; what counts as compliance is not

The classification guidelines the Commission was required to publish by 2026-02-02 under Article 6(5) were still in draft on 2026-10-03. Three draft volumes were published on 2026-05-19; the targeted consultation closed on 2026-07-23, and the consultation page says the final guidelines will be adopted by the end of 2026. No harmonised standard from CEN-CENELEC JTC 21 had been cited in the Official Journal by 2026-10-03, checked through the Publications Office database because the EUR-Lex search itself refuses automated clients. CEN-CENELEC has announced EN 18286 (quality management for AI) as published; publication by a standards body is not citation in the Official Journal, and only citation gives a presumption of conformity. You can know when the obligations begin without yet knowing what satisfying them looks like.

The fines, and the small-company rule that changes them

Prohibited practices: EUR 35 million or 7% of worldwide annual turnover, whichever is higher. Most other operator obligations, including Article 50: EUR 15 million or 3%, whichever is higher. Supplying incorrect or misleading information: EUR 7.5 million or 1%. For small and medium-sized enterprises including start-ups, Article 99(6) inverts this to whichever is lower, across all three tiers. The amendment added Article 99(6a) for small mid-cap companies, which takes the lower figure but only for the second and third tiers — prohibited practices stay on the higher rule. As of 2026-10-03 we found no officially confirmed enforcement decision; figures circulating in commercial blogs are mutually inconsistent and are not repeated here.

In the text Source re-checked Art. 99(3) · Art. 99(4) · Art. 99(5) · Art. 99(6) · Art. 99(6a) · Art. 101 Regulation (EU) 2024/1689, consolidated text ... Regulation (EU) 2026/1744 (Digital Omnibus on... Commission page on the enforcement framework ...

The AI Act does not replace data protection law

The two apply in parallel and compliance with one is not compliance with the other; Article 2(7) preserves the GDPR. One AI-Act-specific permission matters for anyone checking models for bias: the new Article 4a allows processing of special categories of personal data for that purpose, under six conditions, and reaches systems that are not high-risk. If you handle genetic or health data, Article 9 GDPR governs it whatever the AI Act says, and Article 9(4) lets Member States add further conditions on genetic data, so national law varies.

In the text Source re-checked Art. 2(7) · Art. 4a · GDPR Art. 9 Regulation (EU) 2024/1689, consolidated text ... GDPR Article 9 — processing of special catego...

Where our own services sit

We publish our own reading of where our services sit, with the same citations, so that it can be checked and contradicted. Nothing here is a claim that a regulator has agreed with us.

ServicePriceYou submitYou receiveHuman review
Paper assessment (Tier-1)
/assess/tier1
free a DOI and the paper's text, pasted or uploaded a staged reproducibility assessment, as an unsigned draft None
Draft check
/assess/draft
free a manuscript before submission the same Tier-1 assessment None
Help chat
/chat, on every page
free a question typed into the widget a short answer from a language model None

A third tier, which executes a paper's code, exists in the codebase and has no public endpoint.

QuestionOur answerWhyArticles
Is it inside the territorial scope? Yes We are based in Switzerland — in neither the EU nor the EEA — but output used in the Union brings us in. Art. 2(1)(c)
Does being free keep us out? No Supply free of charge is still supply. Art. 3(10)
Any prohibited practice? No — 0 of 10 What is judged is a paper, a manuscript or code. No listed practice is engaged; in particular we do not infer anything about people from biometric data. Art. 5
High-risk via Annex III? No — 0 of 8 areas No area covers research tools or laboratory analysis. Art. 6(2) · Annex III
High-risk via Annex I? No The services are not a medical device or an IVD. Art. 6(1) · Annex I
Are we a general-purpose AI model provider? No We call a third-party model through an API and do not fine-tune it. We are a provider of AI systems. Art. 3(63) · Ch. V
Does the research exemption cover us? We do not rely on it Our tools are used in the conduct of other people's research, which Recital 25 keeps inside the Regulation. Art. 2(6) · Recital 25
Does open-sourcing our code exempt us? No The assessment code is MIT-licensed, but Art. 2(12) does not reach Article 50. We publish it so that a third party can reproduce a verdict independently, not to claim an exemption. Art. 2(12)
What actually applies? Article 4 and Article 50 AI literacy, and the transparency duties that do not depend on risk tier. The help chat is the clearest Article 50(1) case: it interacts directly with a person. Its widget is labelled 'KairosChain Assistant · Beta' and does not yet say that a language model answers. Art. 4 · Art. 50

Facts we state about ourselves

  • No running service ingests human genomic data or patient data. The assessment inputs are manuscript text and an extension-limited set of workflow configuration files. Personal data is processed in the ordinary way — a contact form, the submitter's IP address stored with each assessment and not currently purged, and chat transcripts.
  • The assessment services and the help chat are fully automatic. No person reviews an assessment or a chat answer before it reaches the requester.
  • Assessment results are reached by an unguessable token and are never listed, because a named per-paper score needs human sign-off and an author right of reply before it may be published.
  • Records held on our anchor are recorded but not published. A record is our own timestamped hash of a verdict; the anchor's public key is not yet distributed, so a third party cannot yet verify one.
  • The assessment code is published under the MIT licence, so the same assessment can be run by someone else on their own infrastructure.

What we have not resolved

We publish these rather than pick an answer, because we have found no authority that has interpreted them.

  • Does Article 50(1) reach an endpoint where you submit a paper and receive a verdict — is it a system intended to interact directly with a natural person, and if so is the AI involvement obvious? (The help chat is not in doubt; the assessment endpoints are.) (Art. 50(1))
  • Does an assessment report count as synthetic content requiring a machine-readable mark, or does it fall within the Article 50(2) carve-out for content that does not substantially alter the input? (Art. 50(2))
  • Would releasing per-paper verdicts on request, rather than publishing them, count as text published to inform the public under Article 50(4)? (Art. 50(4))
  • Does Article 2(6) reach analysis offered as a service to third parties at all? We assume it does not. (Art. 2(6))

Sources

Everything above resolves to one of these. Primary means the Official Journal text; official guidance means a Commission document; secondary and academic sources are marked so you can weigh them accordingly.

SourceKindChecked
Regulation (EU) 2024/1689, as published in the Official Journal
https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=OJ:L_202401689
primary 2026-09-13
Regulation (EU) 2024/1689, consolidated text as amended, in force from 2026-07-27
https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:02024R1689-20260727
primary 2026-09-13
Regulation (EU) 2026/1744 (Digital Omnibus on AI), the amending act
https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=OJ:L_202601744
primary 2026-09-13
Commission guidelines on the definition of an AI system
https://digital-strategy.ec.europa.eu/en/library/commission-publishes-guidelines-ai-system-definition-facilitate-first-ai-acts-rules-application
official-guidance 2026-09-13
Commission guidelines on the scope of the obligations for general-purpose AI models
https://digital-strategy.ec.europa.eu/en/library/guidelines-scope-obligations-providers-general-purpose-ai-models-under-ai-act
official-guidance 2026-09-13
Commission guidelines on transparency obligations for AI-generated content
https://digital-strategy.ec.europa.eu/en/policies/guidelines-transparency-ai-generated-content
official-guidance 2026-09-13
Commission guidelines on the transparency obligations under Article 50, C(2026) 5054 final, annex approved 2026-07-20 (full text)
https://ai-act-service-desk.ec.europa.eu/sites/default/files/2026-07/guidelines_on_the_implementation_of_the_transparency_obligations_for_certain_ai_systems_under_article_50_of_the_ai_act_bzptwqhk0ikg1dtlddap41psfy_131215.pdf
official-guidance 2026-10-04
Draft Commission guidelines on the classification of high-risk AI systems — still marked draft on 2026-10-03
https://digital-strategy.ec.europa.eu/en/library/draft-commission-guidelines-classification-high-risk-ai-systems
official-guidance 2026-10-03
Commission status page for the high-risk classification guidelines
https://digital-strategy.ec.europa.eu/en/policies/guidelines-ai-high-risk-systems
official-guidance 2026-10-03
Commission targeted consultation on the draft high-risk classification guidelines — closed 2026-07-23
https://digital-strategy.ec.europa.eu/en/consultations/targeted-consultation-draft-guidelines-classification-high-risk-artificial-intelligence-systems
official-guidance 2026-10-03
CEN-CENELEC announcement that EN 18286 (AI quality management) is published, 2026-07-31
https://www.cencenelec.eu/news-events/news/2026/en-in-the-spotlight/2026-07-30-ai-quality-management/
primary 2026-10-03
Commission page on the enforcement framework of the AI Act
https://digital-strategy.ec.europa.eu/en/policies/enforcement-ai-act
official-guidance 2026-10-03
MDCG 2025-6 — interplay between the Medical Device Regulations and the AI Act
https://health.ec.europa.eu/document/download/b78a17d7-e3cd-4943-851d-e02a2f22bbb4_en?filename=mdcg_2025-6_en.pdf
official-guidance 2026-09-13
GDPR Article 9 — processing of special categories of personal data
https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:32016R0679
primary 2026-09-13
Article 2 index entry (secondary index, useful for navigation)
https://artificialintelligenceact.eu/article/2/
secondary 2026-09-13
Article 3 index entry (secondary index, useful for navigation)
https://artificialintelligenceact.eu/article/3/
secondary 2026-09-13
Michele Finck, 'In Search of the Lost Research Exemption: Reflections on the AI Act', GRUR International 74(10), October 2025, pp. 903-904
https://doi.org/10.1093/grurint/ikaf100
academic 2026-09-13
Law-firm note on the omnibus agreement and the postponed high-risk deadlines (used only to cross-check dates)
https://www.gibsondunn.com/eu-ai-act-omnibus-agreement-postponed-high-risk-deadlines-and-other-key-changes/
secondary 2026-09-13
GenomicsChain assessment code — LICENSE file (MIT) in the public repository
https://github.com/masaomi/GenomicsChain_SkillSets/blob/main/LICENSE
primary 2026-09-13

Not legal advice. This is a reading of published texts by the people who build GenomicsChain, written so that our own position can be checked and contradicted. It creates no advice relationship and should not be relied on in place of a qualified opinion.

How this page is maintained. Monthly. Every claim below carries the date it was checked. The underlying research corpus is docs/reports/eu_ai_act_20260913/ in the open-source assessment repository — six of the seven research dossiers (R1-R6). The seventh, an inventory of our own deployment, and the generated report are withheld because they describe the service's security surface and refer to unpublished records. Versions of this page before 0.2.0 said the whole folder was in the public repository, which was not the case.

Found an error? Tell us — corrections are recorded in the dataset with the date they were made.

Revisions.

  • v0.2.0 · 2026-10-04 — Monthly re-check. Read the Commission's Article 50 guidelines (C(2026) 5054, approved 2026-07-20) against this page, which had said it had not yet done so: the two Article 50 carve-outs and the meaning of "published" are now interpreted in the guidelines, and the research-exemption point now says what the guidelines do and do not cover. The carve-outs point moves from "guidance not yet checked" to "in the text". Updated the high-risk guidelines status (still draft; final promised by end of 2026), the harmonised-standards status (none cited; EN 18286 published by CEN-CENELEC but not cited), the enforcement date, and the German-only corrigendum to the amending act. Four sources added. Review cadence set to monthly. No date in the timeline changed. Before publication an independent checking agent read all five edited points against the sources: it confirmed the paragraph citations, and found that the Recital 25 quotation was attributed to the consolidated text, which carries no recitals — now also cited to the Official Journal original — and that a worked example after para. 21 reads more generously than Article 2(6); that example is now stated. Corrected where the research corpus is: earlier versions said it was in the public repository when it was not; six of its seven dossiers are now published there after screening. The consolidated Regulation and the GDPR are now watched through the Publications Office Cellar, so claims resting on them can be re-checked by machine for the first time.
  • v0.1.5 · 2026-09-14 — Marked the self-assessment block as superseded by a separate check record. No claim in it was edited. The separation is the point: a frame that also scores its own author cannot be contested by a reader, because there is nothing to compare the score against. The record it now points at found six places where this block and the running system disagree, including an unlisted fourth service entrance and a public audit endpoint this page never mentions.
  • v0.1.4 · 2026-09-14 — Joined this page to the regulatory watchlist. Each of the 15 sources now carries watch_status, and the 7 that are watched carry the watchlist id whose scan decides their freshness. The 2 that move but cannot be fetched (the consolidated Regulation, GDPR Art. 9 — both behind the EUR-Lex block) are marked unwatchable rather than left blank, because before this change the page's freshness rested on a single hand-set as_of date and nothing said which claims that date actually covered. No claim, verdict or article number changed.
  • v0.1.3 · 2026-09-13 — Corrected where we are based: GenomicsChain is independent of the University of Zurich (which supported it with an Innovation Grant); the sentence now says only that we are based in Switzerland.
  • v0.1.2 · 2026-09-13 — Second review pass: removed the claim that the chat widget already discloses AI; named IP-address storage and dropped an unverified retention period; removed staff-count figures with no source; corrected how the amendment was found; stated that anchor records are not yet third-party verifiable.
  • v0.1.1 · 2026-09-13 — Independent review before first publication: corrected the Article 113 sentence, relabelled the draft check, added the site chat widget to the self-inventory, removed unsupported statements, added a glossary, softened imperatives.
  • v0.1.0 · 2026-09-13 — First draft from the seven research dossiers.